Clinical Trial Update: Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) Trial [NA]

View source ↗

Summary

The Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) Trial sponsored by Hoffmann-La Roche has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cardiovascular Abnormalities | NA | Status: WITHDRAWN